Mann Named Chief of NIAID Respiratory
Dr. Marianne Culkin Mann has been
named chief of the NIAID Respiratory Diseases Branch in the Division
of Microbiology and Infectious Diseases. She will oversee research
in respiratory infectious diseases including influenza, SARS, tuberculosis,
respiratory syncytial virus, as well as a variety of bacterials and
other respiratory pathogens. She and her colleagues monitor research
necessary to push clinical science in respiratory conditions forward.
Mann is also a volunteer staff pulmonologist at the National Naval
Medical Center. Before coming to NIAID last year, she worked in the
Center for Drug Evaluation and Research at FDA as deputy director
of the division of pulmonary and allergy drug products. Mann received
her M.D. from the Medical College of Pennsylvania. She is a fellow
of the American College of Chest Physicians and is board-certified
in internal medicine and critical care medicine.
CSR Appoints Several SRAs
Dr. Richard Bartlett, formerly of the NIAMS
Review Branch, recently joined the Center for Scientific Review as
scientific review administrator for the skeletal muscle and exercise
physiology study section. He is also responsible for orthopedics-related
small business innovative research grant applications. He had postdoctoral
training in pediatric endocrinology at the University of North Carolina.
After further training at Duke University, he joined the faculty of
its medical school. From there, he moved to the University of Miami,
where he focused on preclinical canine models for development of therapies
for Duchenne muscular dystrophies (DMD) and diabetes. His most recent
research detailed the successful use of in vivo gene repair
technology in muscle of the canine DMD model.
Dr. William Elwood is the new scientific review
administrator of the community level health promotion study section
at the Center for Scientific Review. He comes from Monroe County,
Fla., where he was director of research and development for the Guidance
Clinic of the Florida Keys. He procured funding from government and
private sources and also developed program evaluation and service
improvement plans for the county's mental health and substance abuse
agency. Previously, he conducted community-based research on drug
epidemiology, welfare reform issues and STD/HIV-intervention efficacy
studies throughout the United States and Mexico. His publications
have concentrated on the attitudes and beliefs of hard-to-reach populations
and the result of those values on mental health, health-related behaviors
and participation in civic life.
Dr. Dan Gerendasy recently joined the Center
for Scientific Review as a scientific review administrator for the
international and cooperative projects study section 2. He received
an M.S. in biochemistry from Northwestern University and a Ph.D. in
molecular biology from the University of Arizona, where he studied
bacteriophage replication. He then pursued postdoctoral training in
molecular neurobiology at Scripps Research Institute in La Jolla,
Calif., and was subsequently appointed to the faculty in its department
of molecular biology. There, he used biophysical and genetic methods
to study neuroplasticity in the mouse. His work was funded by NINDS
and involved collaborations with groups in Spain and The Netherlands.
Dr. M. Chris Langub recently joined CSR as
scientific review administrator for the urologic and kidney development
and genitourinary diseases study section, which reviews grant applications
related to systemic or local diseases affecting the kidney, urinary
tract and genital systems. His postdoctoral work targeted the central
natriuretic peptide systems. He has worked in the University of Kentucky's
division of nephrology, bone and mineral metabolism. He was also director
of the core lab in the university's General Clinical Research Center.
He and colleagues there developed the methodology for bone molecular
histomorphometry and were involved in the establishment of the core
lab's web site.
Dr. Neelakanta Ravindranath recently joined
the Center for Scientific Review as scientific review administrator
for the development-2 study section. He came from NICHD, where he
was an intramural researcher in the Laboratory of Clinical Genomics.
Ravindranath holds a Ph.D. in biochemistry from the Indian Institute
of Science, Bangalore, India, as well as a doctoral degree in veterinary
medicine and an M.S. in virology. He obtained his postdoctoral training
at the University of Pittsburgh and the Clinical Research Institute
of Montreal. He served as assistant/associate professor of cell biology
at Georgetown University. His research interests have centered on
the cell and molecular biology of male germ cell differentiation.
He also taught embryology, histology and gross anatomy to medical
students. He served as a regular member of reproductive endocrinology
study section. He was also a member of review committees at Andrew
Mellon/CONRAD and the Phillip Morris Research Foundations. His publications
include 55 journal articles, 16 book chapters and meeting proceedings,
and 7 review articles.
NIAID Council Gains Five
Five people were recently named to the National Advisory Allergy and
Infectious Diseases Council, the principal advisory body of NIAID.
They are: Dr. Stanley W. Chapman, professor of medicine and microbiology
and associate vice chancellor for research integrity at the University
of Mississippi Medical Center; Dr. Ruth M. Ruprecht, professor of medicine
in the department of cancer immunology and AIDS at the Dana-Farber Cancer
Institute in Boston; Dr. Nathan M. Thielman, assistant professor of medicine
at Duke University Medical Center; and Dr. Gail Williams Wertz, professor
of microbiology at the University of Alabama School of Medicine. Dr. J.
Brooks Jackson, professor and chairman of pathology at Johns Hopkins Medical
Institutions, was reappointed to another 4-year term.
Chapman's research and clinical interests focus on the pathogenesis,
diagnosis and treatment of fungal infections.
NIAID director Dr. Anthony Fauci (second from l) welcomes advisory council
members (from l) Dr. Gail Williams Wertz, Dr. Ruth M. Ruprecht, Dr. Stanley
W. Chapman, and Dr. Nathan M. Thielman. Not pictured is Dr. J. Brooks
Jackson is also director of the clinical HIV laboratory at Johns Hopkins
Hospital. His research includes involvement in clinical HIV therapeutic
and prevention trials in the United States, Uganda and China.
Ruprecht's primary research interest is HIV/AIDS, including a program
focused on both understanding the basic molecular mechanisms involved
in HIV replication and developing novel therapeutic concepts.
Thielman is also senior research fellow in the Health Inequalities Program
at Duke. His research interests include infectious diarrhea and HIV/AIDS
Wertz's research focuses on RNA viruses, including human respiratory
syncytial virus, a major cause of illness in infants and children.
Up to Top